Mostrar el registro sencillo del ítem

dc.contributor.authorLozano Rodríguez, Noelia
dc.contributor.authorGomez-Samblas, Mercedes
dc.contributor.authorOsuna Carrillo De Albornoz, Antonio 
dc.date.accessioned2023-12-13T13:22:22Z
dc.date.available2023-12-13T13:22:22Z
dc.date.issued2023-09-08
dc.identifier.citationLozano N, Samblas MG, Calabuig E, Giménez Martí MJ, Gómez Ruiz MD, Arce JMS, et al. (2023). Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease. PLoS ONE 18(9): e0282814. [https://doi.org/10.1371/journal.pone.0282814]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/86162
dc.descriptionThis research was funded by the ERANet program, Research in prevention of congenital Chagas disease: parasitological, placental and immunological markers (ERANet17/HLH-0142 (Cochaco). Instituto Carlos III, Ministerio de Sanidad, Gobierno de Espana. Fundacion Ramon Areces "Interactoma de las exovesiculas de T. cruzi y de los inmunocomplejos que forman con las celulas del hospedador: implicaciones en la patologia de la enfermedad de Chagas (2019)". PreChag y el titulo Exovesiculas circulantes como marcadoras de diagnostico, PREcoz de la Enfermedad de CHAGas del XXI Concurso Nacional para la adjudicacion de Ayudas a la Investigacion en Ciencias de la Vida y de la Materia (2022). Ministerio de Ciencia y Tecnologia of the government of Spain funded the project PGC2018-099424-B-I00 and The financial support given by the proyect A-BIO-350-UGR18 I+D+i Proyect "Programa Operativo FEDER de Andalucia JJAA" 2014-2020.es_ES
dc.description.abstractChagas disease, a neglected tropical disease, is now considered a worldwide health concern as a result of migratory movements from Central and South America to other regions that were considered free of the disease, and where the epidemiological risk is limited to transplacental transmission or blood or organ donations from infected persons. Parasite detection in chronically ill patients is restricted to serological tests that only determine infection by previous infection and not the presence of the parasite, especially in patients undergoing treatment evaluation or in newborns. We have evaluated the use of nucleic acids from both circulating exovesicles and cell-free DNA (cfDNA) from 50 samples twice randomly selected from a total of 448 serum samples from immunologically diagnosed patients in whom the presence of the parasite was confirmed by nested PCR on amplicons resulting from amplification with kinetoplastid DNA-specific primers 121F-122R. Six samples were randomly selected to quantify the limit of detection by qPCR in serum exovesicles. When the nucleic acids thus purified were assayed as a template and amplified with kinetoplastid DNA and nuclear satellite DNA primers, a 100% positivity rate was obtained for all positive samples assayed with kDNA-specific primers and 96% when SAT primers were used. However, isolation of cfDNA for Trypanosoma cruzi and amplification with SAT also showed 100% positivity. The results demonstrate that serum exovesicles contain DNA of mitochondrial and nuclear origin, which can be considered a mixed population of exovesicles of parasitic origin. The results obtained with serum samples prove that both cfDNA and Exovesicle DNA can be used to confirm parasitaemia in chronically ill patients or in samples where it is necessary to demonstrate the active presence of the parasite. The results confirm for the first time the existence of exovesicles of mitochondrial origin of the parasite in the serum of those affected by Chagas disease.es_ES
dc.description.sponsorshipERANet17/HLH-0142es_ES
dc.description.sponsorshipInstituto Carlos III, Ministerio de Sanidad, Gobierno de Españaes_ES
dc.description.sponsorshipFundación Ramón Areceses_ES
dc.description.sponsorshipSpanish Government PGC2018-099424-B-I00es_ES
dc.description.sponsorshipI+D+i Proyect "Programa Operativo FEDER de Andalucia JJAA" A-BIO-350-UGR18es_ES
dc.language.isoenges_ES
dc.publisherPLOSes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleUse of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas diseasees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1371/journal.pone.0282814
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional